Category - Executive Moves

Executive Moves

Aethlon Medical names Charles Fisher as CEO

Aethlon Medical (NASDAQ:AEMD) appointed Charles Fisher, M.D., as CEO, effective Oct. 30. Dr. Fisher joined Aethlon as a member of its board and served as its chairman since November 2017. He succeeds Dr. Timothy Rodell...

November 3, 2020

Executive Moves

iBio appoints global biotech operations expert, Randy Maddux, as COO

Randy Maddux iBio (NYSE AMERICAN:IBIO) appointed biotech industry veteran, Randy Maddux, as COO, effective Dec. 1. Mr. Maddux has more than 20 years of global biologics drug development and manufacturing, business...

November 3, 2020

Executive Moves

Soliton appoints Brad Hauser as president, CEO

Brad Hauser Soliton (NASDAQ:SOLY) named Brad Hauser as president and CEO as the company prepares for its commercial launch. Mr. Hauser most recently was VP of R&D and general manager for CoolSculpting at Allergan...

November 2, 2020

Executive Moves

Fibrocor names William Fanslow as SVP drug development

William Fanslow Closely-held Fibrocor Therapeutics appointed industry veteran, William Fanslow Ph.D., as SVP of drug development. Dr. Fanslow has more than 20 years of experience in drug development, including both...

October 26, 2020

Executive Moves

Perimeter Medical Imaging AI names Jeremy Sobotta as CEO; Tom Boon as COO

Perimeter Medical Imaging AI (TSXV:PINK; FSE:4PC) appointed Jeremy Sobotta as its new CEO and Tom Boon as its new COO, effective immediately. Mr. Sobotta was most recently Perimeter’s CFO and replaces Tom Boon as CEO...

October 22, 2020

Executive Moves

iBio appoints accomplished financial executive, Gary Sender, to board

Gary Sender iBio (NYSE AMERICAN:IBIO) appointed senior financial executive, Gary Sender, as a director and a member of the board’s compensation committee. In addition, Mr. Sender was appointed chair of iBio’s audit...

October 15, 2020

Executive Moves

iBio appoints senior biopharma executive, Dr. Alexandra Kropotova, to board

Alexandra Kropotova iBio (NYSE AMERICAN:IBIO) appointed senior biopharma executive, Dr. Alexandra Kropotova, as a director and a member of the board’s new science and technology committee. Dr. Kropotova has expertise in...

October 15, 2020

Executive Moves

iBio appoints renowned biopharma executive, Dr. Linda Armstrong, to board

iBio (NYSE AMERICAN:IBIO) appointed Dr. Linda Armstrong, a renowned biopharma executive, as a director and a member of the board’s new science and technology committee. “We are pleased to welcome Dr. Armstrong to our...

October 14, 2020

Executive Moves

Long-time biotech analyst Doug Loe joins Leede Jones Gable

Doug Loe, Ph.D. has joined Leede Jones Gable as it continues to grow its capital markets team, boosting healthcare and biotechnology, and building on recent additions in sales and trading. Dr. Loe, who brings more than...

October 14, 2020

Executive Moves

Kaleido Biosciences names Daniel Menichella as president and CEO

Daniel Menichella Kaleido Biosciences (NASDAQ:KLDO) appointed Daniel Menichella as president and CEO, effective Oct. 13. Mr. Menichella will replace Alison Lawton, who is stepping down for personal reasons...

October 1, 2020

Category - Executive Moves

Aethlon Medical names Charles Fisher as CEO

iBio appoints global biotech operations expert, Randy Maddux, as COO

Soliton appoints Brad Hauser as president, CEO

Fibrocor names William Fanslow as SVP drug development

Perimeter Medical Imaging AI names Jeremy Sobotta as CEO; Tom Boon as COO

iBio appoints accomplished financial executive, Gary Sender, to board

iBio appoints senior biopharma executive, Dr. Alexandra Kropotova, to board

iBio appoints renowned biopharma executive, Dr. Linda Armstrong, to board

Long-time biotech analyst Doug Loe joins Leede Jones Gable

Kaleido Biosciences names Daniel Menichella as president and CEO

General

More